Violacein improves vemurafenib response in melanoma spheroids-Reference-Cited by-同舟云学术

Violacein improves vemurafenib response in melanoma spheroids

Published:2023-08-12 Issue: Volume: Page:1-4
ISSN:1478-6419
Container-title:Natural Product Research
language:en
Short-container-title:Natural Product Research

Author:

Aires-Lopes Beatriz¹,Justo Giselle Zenker²,Cordeiro Helon Guimarães¹,Durán N.³⁴,Azevedo-Martins Jordana Maria¹,Ferreira Halder Carmen Veríssima¹

Affiliation:

1. Department of Biochemistry and Tissue Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil

2. Department of Pharmaceutical Sciences and Department of Biochemistry, Federal University of São Paulo (UNIFESP), Diadema, SP, Brazil

3. Department of Structural and Functional Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil

4. Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP, Brazil

Funder

Sao Paulo Research Foundation

National Council for Scientific and Technological Development

Conselho Nacional de Desenvolvimento Científico e Tecnológico;Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Informa UK Limited

Subject

Organic Chemistry,Plant Science,Biochemistry,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14786419.2023.2244134

Reference13 articles.

1. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

2. The role of BRAF V600 mutation in melanoma

3. Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target

4. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

5. GLOBOCAN-Global Cancer Observatory. 2020. Melanoma of skin. World Health Organization. [accessed 2022 Sept 3]. https://gco.iarc.fr/today/data/factsheets/cancers/16-Melanoma-of-skin-fact-sheet.pdf.